<?xml version='1.0' encoding='utf-8'?>
<document id="28946176"><sentence text="Species-related exposure of phase II metabolite gemfibrozil 1-O-β-glucuronide between human and mice: A net induction of mouse P450 activity was revealed."><entity charOffset="48-77" id="DDI-PubMed.28946176.s1.e0" text="gemfibrozil 1-O-β-glucuronide" /></sentence><sentence text="Gemfibrozil is a fibrate drug used widely for dyslipidemia associated with atherosclerosis"><entity charOffset="0-11" id="DDI-PubMed.28946176.s2.e0" text="Gemfibrozil" /><entity charOffset="17-24" id="DDI-PubMed.28946176.s2.e1" text="fibrate" /><pair ddi="false" e1="DDI-PubMed.28946176.s2.e0" e2="DDI-PubMed.28946176.s2.e0" /><pair ddi="false" e1="DDI-PubMed.28946176.s2.e0" e2="DDI-PubMed.28946176.s2.e1" /></sentence><sentence text=" Clinically, both gemfibrozil and its phase II metabolite gemfibrozil 1-O-β-glucuronide (gem-glu) are involved in drug-drug interaction (DDI)"><entity charOffset="18-29" id="DDI-PubMed.28946176.s3.e0" text="gemfibrozil" /><entity charOffset="58-87" id="DDI-PubMed.28946176.s3.e1" text="gemfibrozil 1-O-β-glucuronide" /><pair ddi="false" e1="DDI-PubMed.28946176.s3.e0" e2="DDI-PubMed.28946176.s3.e0" /><pair ddi="false" e1="DDI-PubMed.28946176.s3.e0" e2="DDI-PubMed.28946176.s3.e1" /></sentence><sentence text=" But the DDI risk caused by gem-glu between human and mice has not been compared" /><sentence text=" In this study, six volunteers were recruited and took a therapeutic dose of gemfibrozil for 3 days for examination of the gemfibrozil and gem-glu level in human"><entity charOffset="77-88" id="DDI-PubMed.28946176.s5.e0" text="gemfibrozil" /><entity charOffset="123-134" id="DDI-PubMed.28946176.s5.e1" text="gemfibrozil" /><pair ddi="false" e1="DDI-PubMed.28946176.s5.e0" e2="DDI-PubMed.28946176.s5.e0" /><pair ddi="false" e1="DDI-PubMed.28946176.s5.e0" e2="DDI-PubMed.28946176.s5.e1" /></sentence><sentence text=" Male mice were fed a gemfibrozil diet (0"><entity charOffset="22-33" id="DDI-PubMed.28946176.s6.e0" text="gemfibrozil" /></sentence><sentence text="75%) for 7 days, following which a cocktail-based inhibitory DDI experiment was performed" /><sentence text=" Plasma samples and liver tissues from mice were collected for determination of gemfibrozil, gem-glu concentration and cytochrome p450 enzyme (P450) induction analysis"><entity charOffset="80-91" id="DDI-PubMed.28946176.s8.e0" text="gemfibrozil" /></sentence><sentence text=" In human, the molar ratio of gem-glu/gemfibrozil was 15% and 10% at the trough concentration and the concentration at 1"><entity charOffset="38-49" id="DDI-PubMed.28946176.s9.e0" text="gemfibrozil" /></sentence><sentence text="5 h after the 6th dose" /><sentence text=" In contrast, this molar ratio at steady state in mice was 91%, demonstrating a 6- to 9-fold difference compared with that in human" /><sentence text=" Interestingly, a net induction of P450 activity and in vivo inductive DDI potential in mice was revealed" /><sentence text=" The P450 activity was not inhibited although the gem-glu concentration was high" /><sentence text=" These data suggested species difference of relative gem-glu exposure between human and mice, as well as a net inductive DDI potential of gemfibrozil in mouse model"><entity charOffset="138-149" id="DDI-PubMed.28946176.s14.e0" text="gemfibrozil" /></sentence><sentence text="" /></document>